Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Sarkis

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 24, 2021
The nivolumab/cabozantinib combination and the future of doublets in advanced renal cell cancer treatmentEddy Lilly, Julien Sarkis
Arab Journal of Urology|October 8, 2020
Re: Urological surgery in the COVID-19 era: Patient counselling and informed consentJulien Sarkis, Pierre Sarkis
Arab Journal of Urology|January 11, 2021
Human epidermal growth factor receptor 2 (HER2) and the future of bladder carcinomaJulien Sarkis, Marwan Alkassis, Joy Assaf
Journal of the American Academy of Dermatology|May 28, 2021
Reply to: Tapinarof cream 1% once daily and benvitimod 1% twice daily are two distinct topical medicationsJoy Assaf, Julien Sarkis, Roland Tomb
Journal of the American Academy of Dermatology|January 28, 2021
Tapinarof and the future of topical treatments in plaque psoriasisJoy Assaf, Julien Sarkis, Roland Tomb
Future Oncology (London, England)|February 3, 2021
Combination of cabozantinib and immune checkpoint inhibitors in advanced renal cell carcinoma: update from the European Society for Medical Oncology 2020Julien Sarkis, Nour Khalil, Marwan Alkassis
Asian Journal of Endoscopic Surgery|May 29, 2024
Robotic-assisted native pyeloureterostomy with indocyanine green, after kidney transplantationNour Khalil, Julien Sarkis, Alexandre Ingels
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 20, 2021
Use of immunotherapy with programmed cell death 1 vs programmed cell death ligand 1 in renal cell carcinoma: Lessons from CheckMate 9ER and IMmotion 151Nour Khalil, Julien Sarkis, Georges Abi Tayeh
Future Science OA|September 25, 2020
Bladder cancer during the COVID-19 pandemic: the calm before the storm?Julien Sarkis, Ramy Samaha, Joseph Kattan, et al.
Immunotherapy|January 5, 2021
Maintenance avelumab in metastatic bladder cancer as a step towards sequencing immunotherapyHady Samaha, Ramy Samaha, Julien Sarkis, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 24, 2021
The nivolumab/cabozantinib combination and the future of doublets in advanced renal cell cancer treatmentEddy Lilly, Julien Sarkis
Arab Journal of Urology|October 8, 2020
Re: Urological surgery in the COVID-19 era: Patient counselling and informed consentJulien Sarkis, Pierre Sarkis
Arab Journal of Urology|January 11, 2021
Human epidermal growth factor receptor 2 (HER2) and the future of bladder carcinomaJulien Sarkis, Marwan Alkassis, Joy Assaf
Journal of the American Academy of Dermatology|May 28, 2021
Reply to: Tapinarof cream 1% once daily and benvitimod 1% twice daily are two distinct topical medicationsJoy Assaf, Julien Sarkis, Roland Tomb
Journal of the American Academy of Dermatology|January 28, 2021
Tapinarof and the future of topical treatments in plaque psoriasisJoy Assaf, Julien Sarkis, Roland Tomb
Future Oncology (London, England)|February 3, 2021
Combination of cabozantinib and immune checkpoint inhibitors in advanced renal cell carcinoma: update from the European Society for Medical Oncology 2020Julien Sarkis, Nour Khalil, Marwan Alkassis
Asian Journal of Endoscopic Surgery|May 29, 2024
Robotic-assisted native pyeloureterostomy with indocyanine green, after kidney transplantationNour Khalil, Julien Sarkis, Alexandre Ingels
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 20, 2021
Use of immunotherapy with programmed cell death 1 vs programmed cell death ligand 1 in renal cell carcinoma: Lessons from CheckMate 9ER and IMmotion 151Nour Khalil, Julien Sarkis, Georges Abi Tayeh
Future Science OA|September 25, 2020
Bladder cancer during the COVID-19 pandemic: the calm before the storm?Julien Sarkis, Ramy Samaha, Joseph Kattan, et al.
Immunotherapy|January 5, 2021
Maintenance avelumab in metastatic bladder cancer as a step towards sequencing immunotherapyHady Samaha, Ramy Samaha, Julien Sarkis, et al.
Pageof 4